Management of Sexual Dysfunction in Women
Abstract
Female sexual dysfunction (FSD) is a problem with few treatment options, affecting approximately 40% of women. FSD is closely related to aging and is a common condition. Common symptoms of FSD include decreased vaginal lubrication, pain and discomfort during intercourse, decreased sensation of arousal, and difficulty achieving orgasm. During such discomfort, only a small part of women consult a doctor. Compared to the vast research and treatment for erectile dysfunction in men, particularly with the development of phosphodiesterase type 5 inhibitors, FSD has been significantly understudied and treatment has been limited primarily to psychological therapy. A number of cardiovascular diseases have been associated with FSD, including atherosclerosis, peripheral arterial disease, and hypertension. But more information needs to be learned to properly treat women with FSD.
References
Banaei M, Moridi A, Dashti S. Sexual dysfunction and its associated factors after delivery: a longitudinal study in Iranian women. Materia socio‐medica. 2018;30(3):198.
Camara A, Tounkara TM, Delamou A, Baldé R, Leno NN, Kuotu GC, et al. Prevalence and risk factors of female sexual dysfunction among women infected with HIV in Conakry. Clin Epidemiol Global Health. 2021;12: 100828.
Adebusoye L, Ogunbode O, Owonokoko M, Ogunbode A, Aimakhu C. Factors associated with sexual dysfunction among female patients in a Nigerian ambulatory primary care setting. Annals of Ibadan Postgraduate Medicine. 2020;18(1):9‐17
Olugbenga‐Bello A, Adebayo K, Goodman O, Oke O, Olukunle T. Prevalence and socio‐demographic determinants of sexual dysfunction among Married Women of Reproductive Age Group in South West Nige‐Ria. J Reprod Med Gynecol Obstet. 2020;5:046.
Ghiasi A, Keramat A. Prevalence of sexual dysfunction among reproductive‐age women in Iran: a systematic review and meta‐analysis. J Midwifery Reproductive Health. 2018;6(3):1390–8.
Halle‐Ekane GE, Timti LF, Tanue EA, Ekukole CM, Yenshu EV. Prevalence and Associated factors of female sexual dysfunction among sexually active students of the University of Buea. Sex Med. 2021;9(5):100402.
Madbouly K, Al‐Anazi M, Al‐Anazi H, Aljarbou A, Almannie R, Habous M, et al. Prevalence and predictive factors of female sexual dysfunction in a sample of Saudi Women. Sex Med. 2021;9(1):100277.
Gutzeit O, Levy G, Lowenstein L. Postpartum female sexual function: risk factors for postpartum sexual dysfunction. Sex Med. 2020;8(1):8–13.
Asefa A, Nigussie T, Henok A, Mamo Y. Prevalence of sexual dysfunction and related factors among Diabetes Mellitus patients in Southwest Ethiopia. BMC Endocr Disorders. 2019;19(1):1–8.
Mateu Arrom L, Girabent‐Farrés M, González M, Palou J, Errando‐Smet C, Ramírez‐García I. Development and validation of a short version of the female sexual function index in the Spanish population. BMC Womens Health. 2021;21(1):1–8.
Ejigu AK, Zewlde KH, Muluneh NY, Seraj ZR, GebreLibanos MW, Bezabih YH. Sexual dysfunction and associated factors among patients with Epilepsy at Amanuel Mental Specialty Hospital, Addis Ababa–Ethiopia. BMC Neurol. 2019;19(1):1–13.
Shitu S, Abebe H, Adane D, Wassie A, Mose A, Yeshaneh A. Knowledge of neonatal danger signs and associated factors among husbands of mothers who gave birth in the last 6 months in Gurage Zone, Southern Ethiopia, 2020: a community‐based cross‐sectional study. BMJ Open. 2021;11(8): e045930.
Maroufizadeh S, Riazi H, Lotfollahi H, Omani‐Samani R, Amini P. The 6‐item female sexual function index (FSFI‐6): factor structure, reliability, and demographic correlates among infertile women in Iran. Middle East Fertility Society Journal. 2020;24(1):1–6.
Faubion SS, Fairbanks F, Kuhle CL, Sood R, Kling JM, Vencill JA, et al. Association between body mass index and female sexual dysfunction: a cross‐sectional study from the data registry on experiences of aging, menopause, and sexuality. J Sex Med. 2020;17(10):1971–80.
Holanda JBL, Richter S, Campos RB, Trindade RFC, Monteiro JCS, Gomes‐Sponholz FA. Relationship of thetype of breastfeeding in the sexual function of women. Rev Latino‐Am Enfermagem. 2021;29:e3438. https://doi.org/10.1590/1518‐8345.3160.3438.
Szöllősi K, Szabó L. The association between infant feeding methods and female sexual dysfunctions. Breastfeed Med. 2021;16(1):93–9.
Dağli E, Kul Uçtu A, Özerdoğan N. Sexual dysfunction in the postpartum period: Its relationship with postpartum depression and certain other factors. Perspect Psychiatr Care. 2021;57:604‐ 9. https://doi.org/10.1111/ppc.12583.
García‐Mejido JA, Idoia‐Valero I, Aguilar‐Gálvez IM, Borrero González C, Fernández‐Palacín A, Sainz JA. Association between sexual dysfunction and avulsion of the levator ani muscle after instrumental vaginal delivery. Acta Obstet Gynecol Scand. 2020;99(9):1246–52.
Eid M, Sayed A, Abdel‐Rehim R, Mostafa T. Impact of the mode of delivery on female sexual function after Childbirth. Int J Impot Res. 2015;27(3):118‐20.
Hidalgo‐Lopezosa P, Pérez‐Marín S, Jiménez‐Ruz A, López‐Carrasco JdlC, Cubero‐Luna AM, García‐Fernández R, et al. Factors associated with postpartum sexual dysfunction in Spanish women: a cross‐sectional study. J Personalized Med. 2022;12(6): 926.
Alidost F, Pakzad R, Dolatian M, Abdi F. Sexual dysfunction among women of reproductive age: a systematic review and meta‐analysis. Int J Reproductive Biomed. 2021;19(5):421.
Logan S, Thu WPP, Ho K, Cauley JA, Kramer MS, Yong E‐L. Sexual inactivity and sexual dysfunction in midlife Singaporean women: a prospective cross‐sectional study of prevalence and risk factors. Maturitas. 2021;152:1‐9
Keywords
classification
scientific studies and research
principles of treatment Qadın cinsi funksiyasının pozulması
təsnifatı
elmi araşdırmalar və tədqiqatlar
müalicə prinsipləri женская сексуальная дисфункция
классификация
аучные исследования и исследования
принципы лечения